University College London Hospitals NHS Foundation Trust has teamed up with IgniteData and AstraZeneca to evaluate how electronic health records to electronic data capture could perform in a clinical setting, in applied clinical trials.In…
Continue Reading
Artificial intelligence can be safely used to improve the accuracy of screening of mammography results, according to a new study published in The Lancet Oncology.More than 80,000 women between the ages of 40 and 80,…
Continue Reading
June saw the publication of a variety of KLAS reports from our more traditional market reports to new ecosystem reports focusing on five individual ambulatory EMR vendors.KLAS strives to make each report a valued…
Continue Reading
Top News
The Defense Health Agency announces that stateside roll out of MHS Genesis has been completed on time and on budget. The Oracle Health-powered EHR will be implemented at DOD facilities overseas in the…
Continue Reading
Researchers at the University of Connecticut have developed an ultrasound implant that can assist in opening the blood brain barrier to allow chemotherapy to enter and treat brain cancer. However, unlike cumbersome ultrasound systems,…
Continue Reading
Patients undergoing chemotherapy and immunotherapy treatment are being offered a new remote care service that monitors their progress and helps them manage symptoms at home.Inhealthcare has partnered with NHS Dorset to launch Oncology Monitoring…
Continue Reading
The National Cancer Centre Singapore, a specialty centre under SingHealth, has started implementing an oncology EMR solution by Altera Digital Health.Called Sunrise Oncology, the solution provides a range of clinician tools, including decision support…
Continue Reading
As the next step in Gloucestershire Hospitals NHS Foundation Trust’s five-year digital transformation journey, it has gone live with an electronic prescribing and medicines administration (ePMA) solution. Provided by Altera Digital Health, the ePMA…
Continue Reading
by Healthcare M&A 06/23/2023 Leave a Comment
What You Should Know:
Quest Diagnostics announced that it has completed its $450M acquisition of Haystack Oncology.Haystack Oncology has developed a highly sensitive minimal-residual disease (MRD) testing technology, based…
Continue Reading
Fuse Oncology, an oncology software solutions company, announces that it has officially closed an oversubscribed Series A. Among the largest contributors were Cone Health Ventures, of Greensboro, N.C., and Northeast Georgia Health Ventures (NGHV), of Gainesville,…
Continue Reading
